Compliance Information

Nasal Continuous Positive Airway Pressure in the Treatment of Obstructive Sleep Apnea.

Six and eighteen month compliance rates for patients using n-CPAP.

  • CPAP provides a pneumatic splint of the upper airway resulting in an increase in the pharyngeal cross sectional area.

  • A full night's polysomnogram demonstrates the optimal CPAP pressure at which consolidated sleep occurs in all sleep positions and stages of sleep.

  • If most apneas and hypopneas are prevented in NREM, and SaO2 stays above 90% in REM withour frequent obstructive breathing events, and an adequate pressure has been identified.

  • There are no definite contraindications to CPAP use, and serious complications appear to be extremely rare.

  • The most common adverse effects are nasal dryness, nasal congestion, rhinorrhea, and sneezing often treated by humidification.

  • Another limiting factor is claustrophobia seen in approximately 2% to 5% of patients trying CPAP in the laboratory.

  • Long-term compliance with CPAP was studied in 121 patients. After 6 months 74.4% were compliant; after 18 months 66.6% reported compliance of symptomatic benefit and general dislike of the system.

  • Compliance of patients followed up at the sleep disorders center (SDC) was: at 6 months 77.8 and at 12 months 72.2, whereas the compliance of patients followed up by the primary care MD (PMD) was 71.0% at 6 months and 61.3 at 12 months.

  • Often, problems that prevent the patient from complying with CPAP can be solved in regular follow-up visits.

Author's Conclusion: CPAP is likely to remain the first choice for treatment of obstructive apnea. Also patients tended toward greater compliance when they received regular follow-up care by a physician with significant experience with this treatment modality.

Q. Stokes Dickins, Nancy A Jenkins, Richard Mrad, Paula K. Schweitzer, James K. Walsh. OPERATIVE TECHNIQUES IN OTOLARYNGOLOGY-HEAD AND NECK SURGERY 1991, Vol. 2, No. 2

back to articles


Copyright © 2001-2003 Respironics, Inc. and its affiliates. All rights reserved.